Furthermore, Zheng et al. have identified SR-B1 as a potential biomarker, and that the use of HPPS as an effective anti-nasopharyngeal carcinoma agent may shed new light on the diagnosis and therapeutics of nasopharyngeal carcinoma 11. The gene discussed is SCARB1; the disease is nasopharyngeal carcinoma.